Age- and time-dependent waning vaccine effectiveness of PPV23 against community-acquired pneumonia among adults aged 60 and older: A cohort study
The 23-valent pneumococcal polysaccharide vaccine (PPV23) is recommended for adults to prevent pneumococcal diseases, while its effectiveness over time remains unclear. This study aimed to assess the age- and time-dependent effectiveness of PPV23 in reducing community-acquired pneumonia (CAP) incide...
Saved in:
| Main Authors: | Biying Wang, Chen Qian, Yanan Wu, Liping Yi, Hongjie Yu, Xiaohua Liu, Yonggen Jiang, Tao Zhang, Genming Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2025.2541508 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating Free PPV23 Vaccination for the Elderly in Nanning, China: A Cost-Effectiveness Analysis
by: Zhengqin Su, et al.
Published: (2025-07-01) -
A mathematical model for distributed waning of vaccine-derived immunity: Characterizing dynamical impact on measles elimination
by: Aniruddha Deka, et al.
Published: (2024-12-01) -
Immunogenicity and safety study of 23-valent pneumococcal polysaccharide vaccine revaccination among elderly individuals aged 60–70 years in Shanghai, China
by: Jing Qiu, et al.
Published: (2025-07-01) -
A narrative review on the effectiveness of PPSV23 vaccination in adults in China
by: Weiyan Zhang, et al.
Published: (2025-12-01) -
Association Between Introduction of the 23-valent Pneumococcal Polysaccharide Vaccine (PPSV23) and Pneumonia Incidence and Mortality Among General Older Population in Japan: A Community-based Study
by: Aya Sugiyama, et al.
Published: (2025-05-01)